Skip to main content

Animations

MJFF Publications

6551 - 6560 of 6570 Results
Title
Year
  • Year
  • 2025
  • 2025
  • 2025
  • 2025
  • 2025
  • 2025
  • 2024
  • 2020
  • 2022
  • 2025
  • Summary Details
    OPEN
    Title: Global cellular proteo-lipidomic profiling of diverse lysosomal storage disease mutants using nMOST
    Journal Name: Science Advances
    Publisher: American Association for the Advancement of Science (AAAS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1126/sciadv.adu5787
    Citation Count: 5
  • Summary Details
    OPEN
    Title: CHCHD2 mutant mice link mitochondrial deficits to PD pathophysiology
    Journal Name: Science Advances
    Publisher: American Association for the Advancement of Science (AAAS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1126/sciadv.adu0726
    Citation Count: 3
  • Summary Details
    OPEN
    Title: Type II kinase inhibitors that target Parkinson’s disease–associated LRRK2
    Journal Name: Science Advances
    Publisher: American Association for the Advancement of Science (AAAS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1126/sciadv.adt2050
    Citation Count: 18
  • Summary Details
    OPEN
    Title: A long-lived pool of PINK1 imparts a molecular memory of depolarization-induced activity
    Journal Name: Science Advances
    Publisher: American Association for the Advancement of Science (AAAS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1126/sciadv.adr1938
    Citation Count: 3
  • Summary Details
    OPEN
    Title: Alpha-synuclein regulates nucleolar DNA double-strand break repair in melanoma
    Journal Name: Science Advances
    Publisher: American Association for the Advancement of Science (AAAS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1126/sciadv.adq2519
    Citation Count: 8
  • Summary Details
    OPEN
    Title: Astrocytic RNA editing regulates the host immune response to alpha-synuclein
    Journal Name: Science Advances
    Publisher: American Association for the Advancement of Science (AAAS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1126/sciadv.adp8504
    Citation Count: 11
  • Summary Details
    OPEN
    Title: Mechanism of human PINK1 activation at the TOM complex in a reconstituted system
    Journal Name: Science Advances
    Publisher: American Association for the Advancement of Science (AAAS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc, cc-by-nc
    DOI - Digital Object Identifier: 10.1126/sciadv.adn7191
    Citation Count: 40
  • Summary Details
    OPEN
    Title: Observation of an α-synuclein liquid droplet state and its maturation into Lewy body-like assemblies
    Journal Name: Journal of Molecular Cell Biology
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1093/jmcb/mjaa075
    Citation Count: 104
  • Summary Details
    OPEN
    Title: Mapping of a N-terminal α-helix domain required for human PINK1 stabilization, Serine228 autophosphorylation and activation in cells
    Journal Name: Open Biology
    Publisher: The Royal Society
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1098/rsob.210264
    Citation Count: 47
  • Summary Details
    OPEN
    Title: Personalised regional modelling predicts tau progression in the human brain
    Journal Name: PLOS Biology
    Publisher: Public Library of Science (PLoS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1371/journal.pbio.3003241
    Citation Count: 10
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.